Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bonten

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
BMJ Open|October 29, 2021
BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)Laure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
The Lancet. Infectious Diseases|November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trialPeter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
The New England Journal of Medicine|April 26, 2023
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care WorkersLaure F Pittet, Nicole L Messina, Francesca Orsini, et al.
The New England Journal of Medicine|October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19, Thomas E Hills, Elizabeth Lorenzi, et al.
Critical Care Medicine|May 8, 2026
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)Madiha Hashmi, Rashan Haniffa, Deva Jayakumar, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial, Charlotte A Bradbury, Bryan J McVerry, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
BMJ Open|October 29, 2021
BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)Laure F Pittet, Nicole L Messina, Kaya Gardiner, et al.
Critical Care (London, England)|November 15, 2022
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trialJean Chastre, Bruno François, Marc Bourgeois, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2023
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch ProtocolDana de Kretser, Jocelyn Mora, Max Bloomfield, et al.
The Lancet. Infectious Diseases|November 26, 2021
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trialPeter G Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana-Arri, et al.
The New England Journal of Medicine|April 26, 2023
Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care WorkersLaure F Pittet, Nicole L Messina, Francesca Orsini, et al.
The New England Journal of Medicine|October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19, Thomas E Hills, Elizabeth Lorenzi, et al.
Critical Care Medicine|May 8, 2026
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)Madiha Hashmi, Rashan Haniffa, Deva Jayakumar, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial, Charlotte A Bradbury, Bryan J McVerry, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
Pageof 12